Osaic Holdings’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Osaic Holdings’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,500	Closed	-$111K	–	7660
2022 Q4	$111K	Sell	5,500 -300	-5%	-$4.6K	﹤0.01%	4351
2022 Q3	$62K	Buy	5,800 +300	+5%	+$3.4K	﹤0.01%	4749
2022 Q2	$66K	Buy	5,500 +75	+1%	+$1.21K	﹤0.01%	4742
2022 Q1	$116K	Sell	5,425 -2,700	-33%	-$71.5K	﹤0.01%	4484
2021 Q4	$273K	Buy	8,125 +1,800	+28%	+$50.2K	﹤0.01%	3663
2021 Q3	$163K	Buy	6,325 +3,200	+102%	+$57.2K	﹤0.01%	4093
2021 Q2	$42K	Hold	3,125	–	–	﹤0.01%	5175
2021 Q1	$32K	Sell	3,125 -250	-7%	-$2.85K	﹤0.01%	5201
2020 Q4	$27K	Sell	3,375 -200	-6%	-$1.57K	﹤0.01%	4983
2020 Q3	$26K	Hold	3,575	–	–	﹤0.01%	4768
2020 Q2	$32K	Sell	3,575 -1,200	-25%	-$12.4K	﹤0.01%	4510
2020 Q1	$45K	Buy	+4,775	New	+$57.2K	﹤0.01%	4062

Osaic Holdings's OPNT Position: Q1 2023 in Review

Osaic Holdings sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 5,500 shares — an estimated $111K sold.

Osaic Holdings first reported a position in OPNT in Q1 2020 and held it in 12 quarters. The position peaked at $273K in Q4 2021. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

Osaic Holdings reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Osaic Holdings sold 5,500 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $111K.
Osaic Holdings first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 12 quarters.
Osaic Holdings's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $273K in Q4 2021.
0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.